Riemerella anatipestifer, Escherichia coli and Avian Pasteurella multocida Trivalent Vaccine, Inactivated

Indication / Application: For the prevention of duck infectious serositis (serotype 2), duck Escherichia coli (serotype O78) and duck Pasteurella multocida (capsular type A).
Manufacturing: Produced in GMP-certified facility
Supply Mode: Bulk Supply / Distributor / OEM Available
Origin: China

Generic Name

Riemerella anatipestifer, Escherichia coli and Avian Pasteurella multocida Trivalent Vaccine, Inactivated

Composition and Content

Disease	Strain	Antigen Content
RA	BZ	≥ 10¹⁰ CFU/ml
E.coli	SG	≥ 2.5 × 10⁹ CFU/ml
FC	1502	≥ 1.2 × 10¹⁰ CFU/ml

Appearance

After standing, the upper layer is clear with a small amount of sediment at the bottom; it becomes a uniform suspension after shaking.

Indications

For the prevention of duck infectious serositis caused by Riemerella anatipestifer serotype 2, colibacillosis caused by Escherichia coli serotype O78, and duck pasteurellosis caused by Pasteurella multocida capsular type A. Immunity develops within 21 days and lasts for 3 months.

Dosage and Administration

Administer subcutaneously in the neck to healthy ducklings 5-7 days of age at 0.25 mL per bird.

Adverse Reactions

Generally, no adverse reactions occur.

Precautions

1. For vaccination of healthy ducks only.
2. Do not freeze or expose this product to high temperatures for prolonged periods.
3. Allow the vaccine to reach room temperature and shake thoroughly before use.
4. Use the vaccine on the day the vial is opened.
5. Thoroughly disinfect injection equipment and the injection site before vaccination.
6. Properly dispose of used vaccine vials, equipment, and unused vaccine.

Specification

250 mL/bottle, 40 bottles/carton; 500 mL/bottle, 20 bottles/carton.

Storage and Shelf Life

Store at 2-8°C. Shelf life: 24 months